# SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

> **NCT02008877** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sarcoma Alliance for Research through Collaboration** · enrollment: 20 (actual)

## Conditions studied

- Malignant Peripheral Nerve Sheath Tumors (MPNST)
- Sarcoma

## Interventions

- **DRUG:** ganetespib
- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT02008877
- **Lead sponsor:** Sarcoma Alliance for Research through Collaboration
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2018-04
- **Final completion:** 2018-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008877, "SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02008877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*